Why the study?
Does cardiac resynchronization therapy reduce mortality and hospitalization in selected patients who have heart failure?
Does cardiac resynchronization therapy reduce mortality and hospitalization in selected patients who have heart failure?
This review highlights the established role of cardiac resynchronization therapy in reducing mortality and hospitalization for selected patients with heart failure.
May support CRT in selected HF patients; leaves open optimal selection and timing criteria.
The prevalence of heart failure is increasing and it is associated with significant mortality and morbidity. Optimal medical therapy improves outcome, but heart failure continues to have a substantial impact on both the individual patient and wider society. Over the last two decades, cardiac resynchronization therapy has revolutionized the treatment of selected patients who have heart failure. Cardiac resynchronization therapy significantly reduces mortality and hospitalization through reverse cardiac remodelling. This review informs non-specialists about cardiac resynchronization therapy and for which patients it should be considered.
No takes yet. Share an insight, caveat, or question.
McAloon et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: